title: Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma.
authors.affiliation: Service de Medecine Interne, Hôpital Bretonneau, 2 Boulevard Tonnellé, FR-37044 Tours, France.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Thoreau
authors.forename: Flora
authors.initials: F
authors.lastname: Gouaillier-Vulcain
authors.forename: Laurent
authors.initials: L
authors.lastname: Machet
authors.forename: Christine
authors.initials: C
authors.lastname: Mateus
authors.forename: Caroline
authors.initials: C
authors.lastname: Robert
authors.forename: Nicole
authors.initials: N
authors.lastname: Ferreira-Maldent
authors.forename: François
authors.initials: F
authors.lastname: Maillot
authors.forename: Bertrand
authors.initials: B
authors.lastname: Lioger
mesh_terms: D000208:Acute Disease; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D000072226:Computed Tomography Angiography; D003920:Diabetes Mellitus / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D017128:Embolectomy / Q000379:methods; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007511:Ischemia / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D035002:Lower Extremity / Q000098:blood supply*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000276:immunology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D013927:Thrombosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000970:Antineoplastic Agents; D007004:Hypoglycemic Agents; D007328:Insulin; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; C582435:pembrolizumab